Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
20,909 total articles
Bicara Therapeutics, a clinical-stage biopharmaceutical company focused on bifunctional therapies targeting solid tumors, announced its plan to report first quarter 2026 financial results and business updates on May 11, 2026. The company will host a conference call and webcast to discuss progress, particularly relating to its lead candidate ficeraf…
Research Frontiers Inc., a Nasdaq-listed technology company specializing in SPD-Smart light-control film technology, announced it will release its Q1 2026 financial results on May 7, 2026, followed by a conference call led by its CEO Joseph M. Harary to discuss financial and operating results as well as recent company developments.
FibroBiologics has released the first cGMP-compliant batch of its investigational drug CYWC628 designed for treating diabetic foot ulcers (DFUs). This release enables the commencement of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and preliminary efficacy of CYWC628. The milestone represents progress in the company’s developmen…
DeFi Development Corp., traded as DFDV on Nasdaq, unveiled a $200 million at-the-market equity facility to acquire more Solana (SOL) tokens and support operational and strategic initiatives. The company implements a treasury strategy focused on accumulating SOL, staking it through its own validator infrastructure for rewards, and engaging in decent…
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company specializing in cell and gene therapies, announced its first quarter 2026 financial results conference call to be held on May 13, 2026. The company highlighted its commercial product ZEVASKYN, a gene therapy for recessive dystrophic epidermolysis bullosa, and its ongoing pipelin…
Dentsply Sirona has introduced Smart View - Detect, the world's first FDA-cleared AI-enabled diagnostic aid designed to enhance the detection of teeth affected by periapical radiolucencies (PARLs) in CBCT scans. This AI support feature increases detection sensitivity by approximately 46%, supports efficient review of complex dental imaging data, an…
GlobalFoundries announced its SCALE optical module solution, the industry's first platform compliant with OCI MSA for co-packaged optics. The solution enhances bandwidth density and scalability for AI data centers by integrating advanced silicon photonics technology, supporting modern AI scale-up architectures and enabling high-speed optical interc…
Barfresh Food Group, a Nasdaq-listed company specializing in frozen ready-to-blend and ready-to-drink beverages, announced its participation in the LD Micro Invitational XVI. CEO Riccardo Delle Coste and CFO Lisa Roger will present on May 19, 2026, and meet with investors to discuss company strategy and performance.
Alico, Inc., a diversified agribusiness and land management company, announced that its CEO, John Kiernan, will present and hold one-on-one meetings with investors at the LD Micro Invitational XVI conference in Los Angeles from May 17-19, 2026. The company recently completed a strategic transformation in 2025 and manages approximately 46,000 acres …
Axe Compute Inc. announced its CEO Chris Miglino will appear on Schwab Network and Cheddar to discuss the company's significant growth, highlighted by a $260 million, three-year enterprise contract for a 2,304-GPU NVIDIA B300 deployment—the largest in Axe Compute’s history. The interviews aim to increase visibility for its neocloud AI infrastructur…
NewGenIVF Group reported robust fiscal year 2025 results highlighted by a significant increase in total assets to $32.7 million and net profit attributable to shareholders of $9.9 million, largely from a bargain purchase gain linked to acquisitions. The company made strategic advances in diversifying its business through expansions in digital asset…
Reliance Global Group, through its biotech division LifeSci Global, completed a strategic investment in Innervate Radiopharmaceuticals, a late-stage developer of PET imaging and therapeutic radiopharmaceuticals focused initially on neuroblastoma with expansion potential in cardiovascular and neurodegenerative diseases. This investment aligns with R…
Candel Therapeutics announced a conference call scheduled for May 15, 2026, to discuss extended follow-up data from the phase 3 clinical trial of aglatimagene besadenovec in intermediate- to high-risk localized prostate cancer, presented at the American Urological Association annual meeting. The call will feature leading prostate cancer specialists…
Athene, a subsidiary of Apollo Global Management, has launched Athene Amplify 3.0, an upgraded registered index-linked annuity (RILA). The new product features expanded buffer options to cater to varied risk appetites, a simplified single-contract structure to streamline the client and financial professional experience, and innovative features like…
Diana Shipping Inc. initiated a fully financed tender offer to acquire all outstanding shares of Genco Shipping & Trading at $23.50 per share in cash, representing a 31% premium to Genco's undisturbed share price. This comes after Genco's Board has refused engagement for five months despite multiple offers. Diana aims to deliver immediate value to …
Vera Therapeutics, a US biotechnology company focused on transformative treatments for immunological diseases, announced its management team will present at the Bank of America Securities 2026 Health Care Conference in Las Vegas, NV. The presentation will include updates on its lead drug candidates atacicept, VT-109, and MAU868, targeting autoimmun…
Tyson Foods, a leading protein company, announced the availability of its second quarter 2026 financial results on its investor relations website. The company will host a conference call and webcast to discuss the results. The earnings release will also be filed with the SEC. Tyson Foods is a well-established company with various iconic food brands…
InflaRx N.V. announced new preclinical data showing that izicopan, their investigational oral C5aR1 inhibitor, demonstrates minimal reactive metabolite formation in human liver microsomes, indicating a potentially safer bioactivation profile compared to the marketed drug avacopan. Izicopan has shown strong pharmacokinetic/pharmacodynamic and safety…
FG Nexus has formed a Special Committee of independent directors to evaluate strategic alternatives, including a potential business combination with FG Communities, a real estate investment company focused on manufactured affordable housing communities. The combination aims to build a leading platform integrating income-producing affordable housing…
Rekor Systems has secured a $16.8 million contract with the Oklahoma District Attorneys Council to continue providing technology for the state's Uninsured Vehicle Enforcement Diversion (UVED) Program. Utilizing advanced AI-powered vehicle recognition sensors, Rekor's technology helps identify uninsured drivers, reducing uninsured motorist rates and…
Hubbell Incorporated announced the acquisition of NSI Industries, a leading manufacturer of electrical fittings and components, for $3 billion in cash. The transaction is expected to strengthen Hubbell's Electrical Solutions segment by adding complementary products and brands, supporting long-term growth driven by electrification trends. The deal i…
Palvella Therapeutics has initiated patient dosing in the Phase 2 LOTU trial evaluating its Fast Track-designated QTORIN™ 3.9% rapamycin anhydrous gel for treating clinically significant angiokeratomas, a rare and debilitating vascular malformation with no approved therapies. The single-arm trial plans to enroll up to 15 patients at U.S. vascular a…
K Wave Media Ltd. (NASDAQ: KWM) announced a strategic transformation involving the sale of its legacy business Play Co., Ltd., eliminating approximately $48 million in debt, and a pivot towards developing and investing in AI infrastructure. The company secured expanded capital access of up to $485 million from Anson Funds to fund this AI infrastruc…
BridgeBio Pharma announced new data presentations from the Phase 3 ATTRibute-CM study of acoramidis for transthyretin amyloid cardiomyopathy at the upcoming ESC Heart Failure 2026 conference. The data highlights acoramidis' positive impact on heart failure progression, biomarkers, and clinical outcomes, supporting its established role in reducing c…
MacroGenics, Inc., a clinical-stage biopharmaceutical company, announced an expanded royalty purchase agreement with Sagard Healthcare Partners involving its cancer drug ZYNYZ® (retifanlimab-dlwr). The deal provides MacroGenics a $60 million upfront payment and potential additional milestones, while Sagard receives capped royalty interests on globa…
